Catherine Schulte
Stock Analyst at Baird
(4.26)
# 427
Out of 5,120 analysts
142
Total ratings
59.17%
Success rate
12.8%
Average return
Main Sectors:
Stocks Rated by Catherine Schulte
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Outperform | $142 → $165 | $135.39 | +21.87% | 18 | Nov 25, 2025 | |
| EXAS Exact Sciences | Maintains: Outperform | $72 → $88 | $102.50 | -14.15% | 15 | Nov 4, 2025 | |
| AVTR Avantor | Maintains: Outperform | $15 → $17 | $11.07 | +53.57% | 14 | Oct 24, 2025 | |
| MTD Mettler-Toledo International | Maintains: Neutral | $1,210 → $1,230 | $1,385.61 | -11.23% | 10 | Aug 4, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $553 → $567 | $581.77 | -2.54% | 28 | Jul 24, 2025 | |
| DHR Danaher | Maintains: Outperform | $226 → $229 | $223.42 | +2.50% | 11 | Jul 23, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Neutral | $3 → $2 | $3.38 | -40.74% | 6 | May 13, 2025 | |
| QGEN Qiagen | Maintains: Neutral | $40 → $41 | $52.18 | -21.52% | 4 | Apr 21, 2025 | |
| TECH Bio-Techne | Downgrades: Neutral | $88 → $68 | $65.25 | +4.21% | 11 | Feb 19, 2025 | |
| CSTL Castle Biosciences | Maintains: Outperform | $42 → $38 | $39.47 | -3.72% | 7 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $56 → $33 | $46.81 | -29.50% | 3 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $335 → $281 | $141.13 | +99.11% | 7 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $208 → $217 | $379.31 | -42.79% | 7 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $20 | $231.10 | -91.35% | 1 | Jun 28, 2018 |
Agilent Technologies
Nov 25, 2025
Maintains: Outperform
Price Target: $142 → $165
Current: $135.39
Upside: +21.87%
Exact Sciences
Nov 4, 2025
Maintains: Outperform
Price Target: $72 → $88
Current: $102.50
Upside: -14.15%
Avantor
Oct 24, 2025
Maintains: Outperform
Price Target: $15 → $17
Current: $11.07
Upside: +53.57%
Mettler-Toledo International
Aug 4, 2025
Maintains: Neutral
Price Target: $1,210 → $1,230
Current: $1,385.61
Upside: -11.23%
Thermo Fisher Scientific
Jul 24, 2025
Maintains: Outperform
Price Target: $553 → $567
Current: $581.77
Upside: -2.54%
Danaher
Jul 23, 2025
Maintains: Outperform
Price Target: $226 → $229
Current: $223.42
Upside: +2.50%
Maravai LifeSciences Holdings
May 13, 2025
Maintains: Neutral
Price Target: $3 → $2
Current: $3.38
Upside: -40.74%
Qiagen
Apr 21, 2025
Maintains: Neutral
Price Target: $40 → $41
Current: $52.18
Upside: -21.52%
Bio-Techne
Feb 19, 2025
Downgrades: Neutral
Price Target: $88 → $68
Current: $65.25
Upside: +4.21%
Castle Biosciences
Mar 1, 2023
Maintains: Outperform
Price Target: $42 → $38
Current: $39.47
Upside: -3.72%
Nov 21, 2022
Maintains: Outperform
Price Target: $56 → $33
Current: $46.81
Upside: -29.50%
Sep 22, 2020
Maintains: Neutral
Price Target: $335 → $281
Current: $141.13
Upside: +99.11%
Oct 30, 2019
Maintains: Neutral
Price Target: $208 → $217
Current: $379.31
Upside: -42.79%
Jun 28, 2018
Maintains: Outperform
Price Target: $17 → $20
Current: $231.10
Upside: -91.35%